Wholesale of pharmaceutical and medical goods
EUROBIOLOGICAL AS
Revenue 2025
NOK 65,000
Operating profit
NOK −41,000
Equity
NOK −142,000
Incorporated
2022
Share capital
NOK 30,000
Key figures · 2025
Current ratio
0.07
Equity ratio
-662.0%
Key figures over time · 2025
| Key figures | 2025 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | -62.4% | |
| Net margin (%%) | -62.4% | |
| Return on assets (%%) | -188.9% | |
| Likviditet | ||
| Current ratio | 0.07 | |
| Working capital | −153k | |
| Soliditet | ||
| Equity ratio (%%) | -662.0% | |
| Debt-to-equity ratio | -1.15 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.